Johnny Olszewski

This resolution requests that the President submit certain information to Congress regarding a reduction in force or the withholding of pay due to the lapse in appropriations (i.e., government shutdown) that began on October 1, 2025. Specifically, the resolution requests that the President submit to Congress any and all documents and communications related to * any proposed reduction in force at a federal agency related to the lapse in appropriations, * efforts to create a legal determination at the Office of Management and Budget finding or suggesting that the Government Employee Fair Treatment Act of 2019 does not create a self-executing requirement that furloughed federal employees must receive pay for the period in which they were furloughed during a lapse in appropriations immediately after the lapse in appropriations ends, and * efforts or plans to withhold pay for the period of the lapse of appropriations for excepted or furloughed federal or District of Columbia employees. The resolution also requests that the President submit to Congress any documents or communications between the President's office, the Vice President's office, the Office of Personnel Management, the Office of Management and Budget, the Office of Special Counsel, and the Merit System Protection Board regarding these topics.

This resolution reaffirms that the Twenty-Second Amendment to the U.S. Constitution (1) applies to two terms in the aggregate as President of the United States, and (2) prohibits President Trump from running for another term as President.

This resolution disapproves of pardons for individuals who were found guilty of assaulting U.S. Capitol Police officers.

**Save Americans from the Fentanyl Emergency Act or the SAFE Act** This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Fentanyl-related substances are currently regulated under schedule I through a temporary order issued by the Drug Enforcement Administration. The temporary order expires on March 31, 2025. It limits mandatory minimum penalties for certain offenses involving fentanyl-related substances, establishes a process to deschedule or remove certain fentanyl-related substances that have a low potential for abuse, and allows federal courts to vacate or reduce sentences for convictions involving a fentanyl-related substance that is descheduled or moved to a schedule other than schedule I or II. The bill establishes a new, alternative registration process for schedule I research. It also makes other changes to registration requirements for conducting research with controlled substances, including * permitting a single registration for related research sites in certain circumstances, * waiving the requirement for a new inspection in certain situations, and * allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration. Finally, the bill requires the Government Accountability Office to analyze the implementation and impact of permanently placing fentanyl-related substances into schedule I of the Controlled Substances Act.